Dashboard
Healthy long term growth as Net Sales has grown by an annual rate of 22.39% and Operating profit at 25.52%
Flat results in May 25
With ROCE of 8.88%, it has a fair valuation with a 0.95 Enterprise value to Capital Employed
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
Concentrix Corp. for the last several years.
Risk Adjusted Returns v/s 
News
Is Concentrix Corp. overvalued or undervalued?
As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears undervalued relative to its peers, with a P/E ratio of 11, a Price to Book Value of 0.90, and an EV to EBITDA of 5.71. In comparison, Genpact Ltd. has a P/E of 14.38 and an EV to EBITDA of 10.34, while ADT, Inc. shows a P/E of 10.02 and an EV to EBITDA of 5.12, highlighting Concentrix's more favorable valuation metrics. Despite its attractive valuation, Concentrix has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -9.87% compared to the S&P 500's 16.30%. This underperformance may suggest that the market has not yet recognized the company's potential, reinforcing the notion that Concentrix is undervalued....
Read MoreIs Concentrix Corp. overvalued or undervalued?
As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 11, a Price to Book Value of 0.90, and an EV to EBITDA of 5.71. In comparison to peers, Genpact Ltd. has a higher P/E ratio of 14.38, while ADT, Inc. shows a more favorable EV to EBITDA of 5.12, reinforcing Concentrix's relative attractiveness. Despite this favorable valuation, Concentrix has underperformed against the S&P 500, with a year-to-date return of -8.48% compared to the index's 16.30%. This underperformance, particularly over the past three years where the stock has declined by 65.62%, suggests that while the company is currently undervalued, market sentiment may still be weighing heavily on its stock price....
Read MoreIs Concentrix Corp. overvalued or undervalued?
As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a more favorable assessment of its value. The company appears undervalued, supported by a P/E ratio of 11, a price-to-book value of 0.90, and an EV to EBITDA ratio of 5.71. In comparison, Genpact Ltd. has a higher P/E ratio of 14.38, while ADT, Inc. shows a more favorable EV to EBITDA of 5.12, highlighting Concentrix's relative attractiveness in the market. Despite the positive valuation indicators, Concentrix has underperformed against the S&P 500, with a year-to-date return of -6.84% compared to the index's 16.30%. This underperformance, particularly over the past three years where the stock has declined by 67.02% against a 76.66% gain for the S&P 500, suggests that while the company is currently undervalued, market sentiment may still be a concern....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Feb 2025
Shareholding Compare (%holding) 
Foreign Institutions
Held in 88 Schemes (39.53%)
Held by 161 Foreign Institutions (42.47%)
Quarterly Results Snapshot (Consolidated) - May'25 - YoY
YoY Growth in quarter ended May 2025 is 1.54% vs 47.44% in May 2024
YoY Growth in quarter ended May 2025 is -37.64% vs -17.03% in May 2024
Annual Results Snapshot (Consolidated) - Nov'24
YoY Growth in year ended Nov 2024 is 35.20% vs 12.49% in Nov 2023
YoY Growth in year ended Nov 2024 is -21.47% vs -28.25% in Nov 2023






